The latest financial statement is for the year ending 2025-12-31.
| Cash Flow | 2025-12-31 |
|---|---|
| Net (loss) earnings | -2,527 |
| Depreciation and amortization | 6,796 |
| Provision for excess and obsolete inventory | 818 |
| Amortization of deferred compensation related to stock-based awards | 1,610 |
| Deferred income tax benefit | -1,032 |
| Other non-cash reconciling items | 344 |
| Trade accounts receivable | -4,530 |
| Inventories | 4,167 |
| Prepaid expenses and other current assets | -331 |
| Other assets | 197 |
| Operating lease liabilities | -2,077 |
| Accounts payable | 3,154 |
| Customer deposits and deferred revenue | 975 |
| Domestic and foreign income taxes payable | 119 |
| Deferred revenue, net of current portion | -377 |
| Accrued expenses and other liabilities | -297 |
| Net cash provided by operating activities | 7,315 |
| Acquisition of business, net of cash acquired | 0 |
| Purchases of property and equipment | 1,632 |
| Net cash used in investing activities | -1,632 |
| Repayments of short-term borrowings, net of proceeds | 4,254 |
| Repayments of long-term debt | 4,100 |
| Repurchases of common stock | 0 |
| Proceeds from stock options exercised | 22 |
| Proceeds from shares sold under employee stock purchase plan | 124 |
| Settlement of employee tax liabilities in connection with treasury stock transaction | 17 |
| Net cash used in financing activities | -8,225 |
| Effects of exchange rates on cash | 770 |
| Net cash used in all activities | -1,772 |
| Cash, cash equivalents and restricted cash at beginning of period | 19,830 |
| Cash, cash equivalents and restricted cash at end of period | 18,058 |
INTEST CORP (INTT)
INTEST CORP (INTT)